22 December 2023: Clinical Research
Efficacy of Continuous-Wave Transscleral Cyclophotocoagulation Post-Pars Plana Vitrectomy in Glaucoma Patients: A Retrospective Study from Poland
Izabela Kuciel-Polczak 12ABCDEF* , Magdalena Kawka-Osuch 1ABE , Katarzyna Krysik 12EF , Dariusz Dobrowolski 134DE , Dominika Janiszewska-Bil 156E , Edward Wylęgała 3DE , Beniamin Oskar Grabarek 6CE , Monika Białkowska 7F , Anita Lyssek-Boroń 128ABDEDOI: 10.12659/MSM.941770
Med Sci Monit 2023; 29:e941770
Table 3 Changes in IOP values depending on the endotamponade used during PPV over the 180-day observation period.
| Type of endotamponade | Median number of medications | Time (days) | Study group (mmHg) | Control group (mmHg) | P value (t test) |
|---|---|---|---|---|---|
| Oil endotamponade | 3 | 0 | 39.43±9.60 | 37.56±8.97 | A |
| 1 | 180 | 17.86±7.13 | 26.30±12.39 | ||
| SF6 endotamponade | 3 | 0 | 44.50±11.47 | – | 0.01446A |
| 1 | 180 | 22.75±5.74 | – | ||
| BSS endotamponade | 3 | 0 | 37.50±4.43 | 28.75±1.89 | 0.000080.000170.010970.01391A |
| 1 | 180 | 15.75±1.26 | 19.00±1.41 | ||
| Data are presented as mean±standard deviation; A Statistically significant differences in IOP values between days 0 and 180 in the study group; B Statistically significant differences in IOP values between days 0 and 180 in the comparison group; C Statistically significant differences in IOP values between the study and comparison groups at 0 day; D Statistically significant differences in IOP values between the study and comparison groups at 180 days. | |||||